Background Pre‐eclampsia is associated with deficient intravascular production of
prostacyclin, a vasodilator, and excessive production of thromboxane, a vasoconstrictor and …

Antiphospholipid syndrome (APS) is a thrombo-inflammatory disease propelled by
circulating autoantibodies that recognize cell surface phospholipids and phospholipid …

The objective was to develop evidence-based recommendations for the management of
antiphospholipid syndrome (APS) in adults. Based on evidence from a systematic literature …

Aspirin or heparin or both for improving pregnancy outcomes in women with persistent
antiphospholipid antibodies and recurrent pregnancy loss - Hamulyák, EN - 2020 | Cochrane …

Objective To perform a systematic literature review (SLR) informing the European
Lmmendations for the management of antiphospholipid syndrome (APS) in adults. Methods …

Although the knowledge of APS pathogenesis has grown in recent years, the management
principles and strategies are largely unchanged. There is an unmet need for evaluating …

Antiphospholipid syndrome (APS), is an acquired autoimmune disorder characterised by
thrombosis, pregnancy morbidity, and the presence of antiphospholipid antibodies (aPL) …

Antiphospholipid syndrome (APS) is a thromboinflammatory disease with a variety of clinical
phenotypes. Primary thrombosis prophylaxis should take an individualized risk stratification …

Objective Obstetric complications are common in patients with antiphospholipid syndrome.
However, the impact of antiphosholipid antibodies (aPL) in the pregnancy outcomes of …

Introduction: Important advancements in pregnancy outcome have been reported in women
with antiphospholipid antibodies (aPL), despite the fact that the treatment of aPL related …